Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$753M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$711M |
| 3 |
Humana
HUM
|
+$617M |
| 4 |
NextEra Energy
NEE
|
+$610M |
| 5 |
British American Tobacco
BTI
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.32B |
| 2 |
STJ
St Jude Medical
STJ
|
+$690M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$629M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$609M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$603M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.39% |
| 2 | Technology | 9.09% |
| 3 | Healthcare | 7.39% |
| 4 | Energy | 7.04% |
| 5 | Consumer Discretionary | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5851
PUT
OneMain Financial
OMF
$7.27B
| $127K | ﹤0.01% |
5,100
+4,800
| +1,600% | +$121K |
|
|
CEMP
5852
PUT
DELISTED
Cempra, Inc.
CEMP
| $127K | ﹤0.01% |
33,800
-28,200
| -45% | -$97.8K |
|
|
VNET
5853
VNET Group
VNET
$1.79B
| $126K | ﹤0.01% |
22,987
-2,384
| -9% | -$16.2K |
|
|
KERX
5854
PUT
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $126K | ﹤0.01% |
20,500
-11,900
| -37% | -$65.2K |
|
|
NSR
5855
PUT
DELISTED
Neustar Inc
NSR
| $126K | ﹤0.01% |
3,800
-13,800
| -78% | -$459K |
|
5856
Constellium
CSTM
$3.76B
| $125K | ﹤0.01% |
19,216
-59,874
| -76% | -$428K |
|
5857
Cohen & Steers Quality Income Realty Fund
RQI
$1.71B
| $125K | ﹤0.01% |
+10,166
| New | +$128K |
|
5858
PUT
Texas Capital Bancshares
TCBI
$4.28B
| $125K | ﹤0.01% |
+1,500
| New | +$126K |
|
5859
Veracyte
VCYT
$4.45B
| $125K | ﹤0.01% |
13,570
-2,969
| -18% | -$24.3K |
|
|
BLPH
5860
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $125K | ﹤0.01% |
+5,600
| New | +$88K |
|
5861
Camtek
CAMT
$5.92B
| $123K | ﹤0.01% |
32,408
-49,993
| -61% | -$181K |
|
|
KYNB
5862
PUT
Kyntra Bio
KYNB
$27.4M
| $123K | ﹤0.01% |
+200
| New | +$122K |
|
|
OREX
5863
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $123K | ﹤0.01% |
35,791
-16,594
| -32% | -$65.5K |
|
|
ETW
5864
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.01B
| $122K | ﹤0.01% |
11,154
-3,741
| -25% | -$40K |
|
5865
Freshpet
FRPT
$3.04B
| $122K | ﹤0.01% |
+11,078
| New | +$120K |
|
|
SUNE
5866
SUNation Energy
SUNE
$8.91M
| – | – |
0
| – | – |
|
|
ALR
5867
DELISTED
AlerisLife Inc
ALR
| $122K | ﹤0.01% |
5,693
+1,011
| +22% | +$24.8K |
|
5868
Axsome Therapeutics
AXSM
$11.7B
| $121K | ﹤0.01% |
+30,920
| New | +$148K |
|
5869
PUT
Box
BOX
$4.49B
| $121K | ﹤0.01% |
7,400
-7,300
| -50% | -$123K |
|
5870
CALL
Global Payments
GPN
$24.1B
| $121K | ﹤0.01% |
+1,500
| New | +$118K |
|
5871
PUT
Leggett & Platt
LEG
$1.4B
| $121K | ﹤0.01% |
2,400
-1,000
| -29% | -$48.8K |
|
5872
CALL
ProShares UltraShort Real Estate
SRS
$14.8M
| $120K | ﹤0.01% |
450
+25
| +6% | +$6.88K |
|
5873
Stagwell
STGW
$2B
| $120K | ﹤0.01% |
12,761
-8,141
| -39% | -$64.1K |
|
5874
PUT
Starwood Property Trust
STWD
$6.12B
| $120K | ﹤0.01% |
5,300
+4,000
| +308% | +$90.3K |
|
|
TOUR
5875
CALL
Tuniu
TOUR
$56.2M
| $120K | ﹤0.01% |
+1,370
| New | +$120K |
|
Similar funds
Goldman Sachs's Q1 2017 Portfolio in Review
As of Q1 2017, Goldman Sachs held 7,322 positions worth $369B, up 4.2% from $354B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Goldman Sachs's Q1 2017 filing shows 455 new, 2,594 increased, 3,387 reduced and 597 closed positions. Its largest new stake was Deutsche Bank Aktiengesellschaft: 36,861,723 shares worth $87M. The largest sale was NVIDIA, an estimated $1.32B.
By sector, the portfolio is most concentrated in Financials at 9.4% of assets, down from 9.9% a quarter earlier, followed by Technology and Healthcare.
- Goldman Sachs's largest Q1 2017 buy was Deutsche Bank Aktiengesellschaft: 36,861,723 shares worth $87M.
- Goldman Sachs added most to Intuitive Surgical in Q1 2017, an estimated $753M increase.
- Goldman Sachs's biggest Q1 2017 reduction was NVIDIA, cutting an estimated $1.32B.
- Goldman Sachs fully exited St Jude Medical in Q1 2017, selling an estimated $690M.
- Goldman Sachs's ten largest holdings make up 16% of its $369B portfolio in Q1 2017.
- Goldman Sachs opened 455 new positions and closed 597 in Q1 2017.
- Goldman Sachs's portfolio value rose 4.2% quarter-over-quarter to $369B.
Based on Goldman Sachs's 13F filing for Q1 2017, filed 15 May 2017.